Circulating tumour cells (CTCs) are cancer cells that escape from primary tumour sites and enter the bloodstream. This metastasis is responsible for the majority of deaths from cancer. Monitoring the level of CTC levels in blood is thus important but has proved difficult to do. A team of researchers in China and the US has now developed a new way to isolate these cells using a technique called size-amplified acoustofluidics in which the CTCs selectively bind to microbeads.
The bound cancer cells are significantly different in terms of size and physical properties (they are stiffer, for example) compared to normal cells, explain the researchers led by Feng Guo of Indiana University in Bloomington in the US. This means that their acoustic radiation force is a 100-fold higher than that of bare CTCs or normal blood cells. They can thus be efficiently sorted from blood using microbeads (the “size-amplifiers”) in a travelling acoustic wave microfluidic device, and then released from the amplifiers by being degraded with enzymes.
The technique is 77% efficient and produces CTCs with a 96% yield.
Image Credit: Huiqin Liu
News This Week
Think that human augmentation is still decades away? Think again. This week, government leaders met with experts and innovators ahead of the World Government Summit in Dubai. Their goal? To determine the future of artificial [...]
It may sound contradictory, but diamonds are the key to a new technique that could provide a very-low-cost alternative to multimillion-dollar medical imaging and drug-discovery devices. An international team led by scientists at the [...]
The University of North Florida Materials Science and Engineering Research Facility (MSERF) has partnered with TESCAN, a leading manufacturer of electron and light microscopes, in the installation of one of its new Q-Phase microscopes, [...]
Circulating tumour cells (CTCs) are cancer cells that escape from primary tumour sites and enter the bloodstream. This metastasis is responsible for the majority of deaths from cancer. Monitoring the level of CTC levels [...]
Cancer is a disease often driven by mutations in genes. As researchers learn more about these genes, and the proteins they code for, they are seeking smarter drugs to target them. The ultimate goal [...]
The University of Warwick and QuantIC researchers at Heriot Watt University and the University of Glasgow performed a study in optical sensing, which could considerably enhance the precision of measuring nanoscopic structures. QuantIC is [...]